Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is an open-label clinical trial (Single Group Assignment) evaluating Bacillus subtilis + Bifidobacterium bifidum + Bifidobacterium breve + Bifidobacterium animalis lactis + Bifidobacterium longum + Lactobacillus brevis + Lactobacillus casei + Lactobacillus paracasei + Lactobacillus plantarum + Lactobacillus rhamnosus + Lactobacillus salivarius + Saccharomyces boulardii in patients with Breast Cancer / Mammacarcinoma (adenocarcinoma)
Mean number of cytotoxic T lymphocytes (CD8+ cells)
No published results were found as of April 2026
…